Spero Therapeutics, Inc. (SPRO)
1.21
-0.01
(-0.82%)
USD |
NASDAQ |
Aug 24, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Debt to Equity Ratio : 0.0462 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0462 |
| March 31, 2026 | 0.0467 |
| December 31, 2025 | 0.0491 |
| September 30, 2025 | 0.1265 |
| June 30, 2025 | 0.1101 |
| March 31, 2025 | 0.1171 |
| December 31, 2024 | 0.0932 |
| September 30, 2024 | 0.0706 |
| June 30, 2024 | 0.0613 |
| March 31, 2024 | 0.0545 |
| December 31, 2023 | 0.0519 |
| September 30, 2023 | 0.1086 |
| June 30, 2023 | 0.1116 |
| March 31, 2023 | 0.0984 |
| December 31, 2022 | 0.0875 |
| September 30, 2022 | 0.2124 |
| June 30, 2022 | 0.1949 |
| March 31, 2022 | 0.9284 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.6314 |
| September 30, 2021 | 0.0646 |
| June 30, 2021 | 0.0824 |
| March 31, 2021 | 0.0643 |
| December 31, 2020 | 0.0594 |
| September 30, 2020 | 0.0605 |
| June 30, 2020 | 0.0754 |
| March 31, 2020 | 0.0662 |
| December 31, 2019 | 0.0744 |
| September 30, 2019 | 0.0497 |
| June 30, 2019 | 0.0444 |
| March 31, 2019 | 0.0445 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Inovio Pharmaceuticals, Inc. | 1.831 |
| Fortress Biotech, Inc. | 0.3248 |
| Kura Oncology, Inc. | 0.5049 |
| Legend Biotech Corp. | 0.2263 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 52.77M |
| Total Liabilities (Quarterly) | 8.562M |
| Shareholders Equity (Quarterly) | 44.20M |
| Current Ratio | 6.121 |
| Net Debt Paydown Yield | 0.30% |